Denville, NJ (PRWEB) January 22, 2015
Diagenode, Inc., a leading global provider of shearing technologies such as the Bioruptor® and complete solutions for epigenetics research, recently launched a full semi-automation system for chromatin immunoprecipitation, alleviating the need for manual processing. The new ChIPettor System includes reagents and controls needed for ChIP of histones or transcription factors and a semi-automated pipette with special resin tips for capture.
“The ChIPettor is quite a handy system for researchers who a need budget-friendly method to quickly and easily perform ChIP,” said Geoffrey Berguet, Product Manager at Diagenode. “The system delivers up to 12 purified immunoprecipitated DNA with less than one hour of hands-on time.”
In the ChIPettor System, a researcher simply sets up the self-standing pipette while it automatically mixes validated ChIP reagents including control antibodies via a pre-programmed protocol. The system has been validated to work with low starting inputs as well.
“Diagenode has focused on delivering solutions to streamline epigenetics research allowing a high degree of quality in results,” said Didier Allaer, CEO of Diagenode. “The ChIPettor System is a smart alternative to tedious manual ChIP.”
More information on Diagenode’s ChIPettor® can be found at http://www.diagenode.com/en/landing-pages/chipettor.php
About Diagenode, Inc.:
Diagenode is a leading provider of complete solutions for epigenetics research and sample preparation. The company has developed both shearing solutions for a number of applications as well as a comprehensive approach to gain new insights into epigenetic studies. The companyoffers innovative shearing and automation instruments, reagent kits, and high quality antibodies to streamline DNA methylation, ChIP, and ChIP-seq workflows. The company’s latest innovations include a unique, full automation system, the industry’s most validated antibodies, and the Megaruptor® shearing system for long fragment generation in sequencing.For more information about Diagenode, please visit the company’s website at http://www.diagenode.com.